REG - Oxford Biomedica PLC - Block listing Return
RNS Number : 8637DOxford Biomedica PLC01 July 2021
For Immediate Release
01 July 2021
OXFORD BIOMEDICA PLC
BLOCK LISTING RETURN
Name of applicant:
OXFORD BIOMEDICA PLC
Name of scheme:
2015 Employee Share Option Scheme
Period of return:
From:
01 Jan 2021
To:
30 June 2021
Balance of unallotted securities under scheme(s) from previous return:
213,198
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
150,000
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
106,654
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
256,544
Name of applicant:
OXFORD BIOMEDICA PLC
Name of scheme:
2015 Long Term Incentive Plan
Period of return:
From:
01 Jan 2021
To:
30 June 2021
Balance of unallotted securities under scheme(s) from previous return:
179,760
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
200,000
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
121,292
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
258,468
Name of applicant:
OXFORD BIOMEDICA PLC
Name of scheme:
2015 Deferred Bonus Plan
Period of return:
From:
01 Jan 2021
To:
30 June 2021
Balance of unallotted securities under scheme(s) from previous return:
155,679
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
100,000
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
28,791
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
226,888
Name of applicant:
OXFORD BIOMEDICA PLC
Name of scheme:
Sharesave Scheme
Period of return:
From:
01 Jan 2021
To:
30 June 2021
Balance of unallotted securities under scheme(s) from previous return:
240,351
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
150,000
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
14,482
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
375,869
Name of contact:
Natalie Walter
Telephone number of contact:
01865 783000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDBLRRBMMTMTJMBJB
Recent news on Oxford BioMedica
See all newsRCS - Oxford Biomedica PLC - Licensing agreement with VVMF
AnnouncementREG - Stock Exch Notice - Admission to Trading - 09/03/2026
AnnouncementREG - Oxford Biomedica PLC - Admission to Trading
AnnouncementREG - Oxford Biomedica PLC - Admission to Trading Application
AnnouncementREG - Oxford Biomedica PLC - Capital Markets Day and investor conferences
Announcement